All IMU need now is a great update report on Checkvacc. If there is any significant positive impact on the patients, there will be no holding back this baby. Not just because of Checkvacc, but also the market factoring in high possibility of success for Vaxinia as well since they are both of the same CF33 platform.
The trial of Checkvacc has been running for 5 months now without any negative news. Surely we are due an update soon.
Ann: Clinical Trial of New Cancer Oncolytic Virotherapy Vaxinia, page-43
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
-0.001(1.89%) |
Mkt cap ! $382.1M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.2¢ | $216.1K | 4.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 1854997 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 382882 | 4 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |